|
|
|
|
|
|
|
|
|
|
|
|
|
|
|

06th Jan 2010
EU Petition
Anyone can sign this EU Petition, so
wherever you are in the world, please support this Petition.
Please click on this link
http://www.ipetitions.com/petition/ldnnow/
NB You may ignore the Pop Up Page
seeking Donations towards the Petition Site. These donations are NOT for LDN.
The EU Petition Reference No.
is 791/2009 – Low Dose Naltrexone
This is what the EU Petition says:
We petition the European Parliament to
make funding available, either directly through taxes or indirectly by directing
research bodies to provide funding, to undergo trials for the generic drug, Low
Dose Naltrexone (LDN). Primarily this is to be done for Cancer since there lies
the biggest savings of life and economy, but then also for the many other
diseases, such as MS, Crohns disease, Fibromyalgia, Rheumatoid Arthritis,
HIV/Aids and many more. Alternatively,
the drug should be made available on the basis of its widespread use and the
widespread positive reports of the many doctors around the world who are
currently using it. The evidence about this drug has overtaken the trials
process already and as such, we ask also that this drug be made available as
front line treatment, now. The research should then be performed to confirm the
drug and resolve the many unanswered questions surrounding it. That a generic drug is proving so important
in saving lives makes the unavailability carry a human rights burden too.
To summarise, we ask for the funding to
be provided and the drug to be made freely available to those who request it. The drug has been proven safe at high
dose usage so the safety trials are done, and we know of no drugs which become
unsafe at low dose when safe at high ones. In 25 years, the drug industry has
ignored this drug due to lack of return on investment, so we believe that only
government led intervention can break this scandalous apathy. LDN now, save our
sick, save our economy.
05th March 2010:
LDNNow has received a letter from the European Parliament. They confirmed that
they had a panel discussion on 27/28 January, and have agreed to ask the
European Commission to further research into LDN, and to continue the
examination of Low Dose Naltrexone.
Wherever you are in the World,
please support the Australian and Canadian Petitions:-
Committed to saving
lives using LDN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|